An Empirical Note on Perceptions of Patients and Physicians in Direct-to-Consumer Promotion of Pharmaceutical Products

Author:

Jha Ajeya1ORCID,Pandey Jaya Rani1ORCID,Mukherjee Samrat Kumar1

Affiliation:

1. Sikkim Manipal University, India

Abstract

Direct promotion of pharmaceutical products to patients is not legal in India. Internet healthcare websites, however, have rendered this law as merely a paper-feast. Patients today increasingly flock to websites to find health related information, including those related to drugs. This paper attempts to identify the differences in the perception of physicians and patients in this context. This is an important issue as differences in perception may result in newer conflict-points between patients and physicians. The study is based on a survey involving 400 patients and 200 physicians. The results indicate that major differences exist in the beliefs held by physicians' and patients' vis-à-vis merits and demerits of DTC-promotion through online-health related websites. As patients and physicians operate as a team while health-solutions are made available to the patients, such major differences in their beliefs regarding the merits and demerits of DTC-promotion may result in emergence of fault-lines in their relationship.

Publisher

IGI Global

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Non-cognitive Differences on Social Media Branded Drugs Promotion: Study of Indian Patients and Physicians;Lecture Notes in Networks and Systems;2022-11-10

2. Impact of Ethicality and Marginalized Group Convenience on Social Media Promotion of Branded Drugs;Advances in Communication, Devices and Networking;2022-08-30

3. Role of Social Media Promotion of Prescription Drugs on Patient Belief-system and Behaviour;Research Anthology on Improving Health Literacy Through Patient Communication and Mass Media;2022

4. Dynamics of Social Media Promotion of Prescription Drugs and Resulting Patient Belief Systems;Advances in Social Networking and Online Communities;2021

5. Self-Medication and Direct-to-Consumer Promotion of Drugs;Advances in Communication, Devices and Networking;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3